Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (7) | Back to Search
PPRCH-33 - Epilepsy Management in Lebanon: Exploring Economic Burden, Quality of Life, and Cost-Effectiveness in the Context of Socioeconomic Challenges
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: PPRCH-33
- By: YOUNES, Samar (School of Pharmacy, Lebanese International University, Lebanon)
- Co-author(s): Dr Samar Younes (School of Pharmacy, Lebanese International University, Bekaa, Lebanon / INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / University of Limoges, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France)
Dr Nisreen Mourad (School of Pharmacy, Lebanese International University, Bekaa, Lebanon / INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / University of Limoges, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France / IVPN-Network, Fujairah, United Arab Emirates)
Dr. Jalal Dahham (INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands)
Prof. Pascale Salameh (INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / Faculty of Pharmacy, Lebanese University, Beirut, Lebanon / Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus / School of Medicine, Lebanese American University, Byblos, Lebanon)
Prof. Clémence Thébaut (University of Limoges, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France) - Abstract:
Introduction
Epilepsy management in Lebanon faces significant challenges amid the country's ongoing economic crisis, with limited research integrating pharmacoeconomic evaluations, medication quality awareness, and patient-reported outcomes. Existing studies suffer from geographical limitations, small sample sizes, and insufficient exploration of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025